ArticleHepatology (Baltimore, Md.)2021

Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.

Laura Torrens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.